Brown, Lisle/Cummings’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$760K Buy
52,918
+2,154
+4% +$32K 0.19% 117
2025
Q4
$764K Buy
50,764
+4,098
+9% +$61.5K 0.19% 121
2025
Q3
$673K Buy
46,666
+1,554
+3% +$22.1K 0.17% 120
2025
Q2
$643K Buy
45,112
+852
+2% +$12.2K 0.17% 121
2025
Q1
$659K Buy
44,260
+1,549
+4% +$24.2K 0.19% 118
2024
Q4
$615K Buy
42,711
+6,198
+17% +$95.9K 0.18% 119
2024
Q3
$578K Buy
36,513
+2,128
+6% +$33.6K 0.18% 120
2024
Q2
$528K Sell
34,385
-1,311
-4% -$19.9K 0.17% 126
2024
Q1
$585K Buy
35,696
+1,063
+3% +$16.8K 0.2% 113
2023
Q4
$507K Buy
34,633
+9,671
+39% +$135K 0.19% 119
2023
Q3
$360K Buy
24,962
+1,250
+5% +$19.5K 0.16% 131
2023
Q2
$389K Buy
23,712
+292
+1% +$4.76K 0.17% 128
2023
Q1
$391K Buy
23,420
+89
+0.4% +$1.43K 0.2% 117
2022
Q4
$360K Buy
23,331
+1,090
+5% +$16.9K 0.19% 118
2022
Q3
$332K Sell
22,241
-402
-2% -$6.65K 0.19% 109
2022
Q2
$372K Buy
22,643
+1,555
+7% +$26.7K 0.21% 110
2022
Q1
$423K Buy
21,088
+15,267
+262% +$317K 0.2% 111
2021
Q4
$148K Buy
+5,821
New +$150K 0.07% 183

Other funds holding BMEZ

Brown, Lisle/Cummings's BMEZ Position: Q1 2026 in Review

Brown, Lisle/Cummings increased its BlackRock Health Sciences Trust II (BMEZ) stake by 4.2% in Q1 2026, buying an estimated $32K and bringing the position to 52,918 shares worth $760K. The position accounts for 0.19% of the portfolio, ranked #117.

Brown, Lisle/Cummings first reported a position in BMEZ in Q4 2021 and has held it in 18 quarters since. The position peaked at $764K in Q4 2025. 88 funds tracked by Wall St. Rank hold BMEZ as of Q1 2026.

  • Brown, Lisle/Cummings held 52,918 shares of BlackRock Health Sciences Trust II worth $760K as of Q1 2026.
  • Brown, Lisle/Cummings bought 2,154 BlackRock Health Sciences Trust II shares in Q1 2026, an estimated $32K.
  • BlackRock Health Sciences Trust II made up 0.19% of Brown, Lisle/Cummings's portfolio in Q1 2026, its #117 holding.
  • Brown, Lisle/Cummings first reported a position in BlackRock Health Sciences Trust II in Q4 2021 and has held it in 18 quarters since.
  • Brown, Lisle/Cummings's BlackRock Health Sciences Trust II position peaked at $764K in Q4 2025.
  • 88 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q1 2026.

Based on Brown, Lisle/Cummings's 13F filing for Q1 2026, filed 20 Apr 2026.